1-2 of 2
Alexander Starodub
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study

Manish A. Shah, Alexander Starodub, Sunil Sharma, Jordan Berlin, Manish Patel, Zev A. Wainberg, Jorge Chaves, Michael Gordon, Kevin Windsor, Carrie Baker Brachmann, Xi Huang, Greg Vosganian, Julia D. Maltzman, Victoria Smith, Jeffrey A. Silverman, Heinz-Josef Lenz, Johanna C. Bendell
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (16): 3829–3837.
https://doi.org/10.1158/1078-0432.CCR-17-2469
Published: 14 August 2018
View article titled, Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study
Open the PDF for Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study in another window
Includes: Supplementary data
Journal Articles

A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma

Sumanta Pal, Arun Azad, Shailender Bhatia, Harry Drabkin, Brian Costello, John Sarantopoulos, Ravindran Kanesvaran, Richard Lauer, Alexander Starodub, Ralph Hauke, Christopher J. Sweeney, Noah M. Hahn, Guru Sonpavde, Stephen Richey, Timothy Breen, Gabriel Kremmidiotis, Annabell Leske, Elizabeth Doolin, David C. Bibby, Jeremy Simpson, Jose Iglesias, Thomas Hutson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3420–3427.
https://doi.org/10.1158/1078-0432.CCR-14-3370
Published: 02 August 2015
View article titled, A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
Open the PDF for A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma in another window
Includes: Supplementary data